BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9285565)

  • 21. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
    Barbeau B; Barat C; Bergeron D; Rassart E
    Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene for porcine pregnancy-associated glycoprotein 2 (poPAG2): its structural organization and analysis of its promoter.
    Szafranska B; Miura R; Ghosh D; Ezashi T; Xie S; Roberts RM; Green JA
    Mol Reprod Dev; 2001 Oct; 60(2):137-46. PubMed ID: 11553911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors.
    Wei Y; Fourel G; Ponzetto A; Silvestro M; Tiollais P; Buendia MA
    J Virol; 1992 Sep; 66(9):5265-76. PubMed ID: 1323693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
    Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
    Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors.
    Flajolet M; Tiollais P; Buendia MA; Fourel G
    J Virol; 1998 Jul; 72(7):6175-80. PubMed ID: 9621085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
    Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
    Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
    Schaffer A; Cerutti A; Shah S; Zan H; Casali P
    J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
    Eisbacher M; Khachigian LM; Khin TH; Holmes ML; Chong BH
    Cell Growth Differ; 2001 Aug; 12(8):435-45. PubMed ID: 11504709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
    Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K
    Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
    Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
    Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional N-myc2 retroposon in ground squirrels: implications for hepadnavirus-associated carcinogenesis.
    Quignon F; Renard CA; Tiollais P; Buendia MA; Transy C
    Oncogene; 1996 May; 12(9):2011-7. PubMed ID: 8649862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.